Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis

Seyyedeh Zahra Safi 1 , *
Author Information
1 Department of Psychology Science, Payame Noor University, Tehran, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: March 28, 2015, 9 (1)
  • Published Online: March 21, 2015
  • Article Type: Original Article
  • Received: July 16, 2014
  • Revised: November 28, 2014
  • Accepted: January 21, 2015
  • DOI: 10.17795/ijpbs340

To Cite: Safi S Z. A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis, Iran J Psychiatry Behav Sci. 2015 ; 9(1):-. doi: 10.17795/ijpbs340.

Abstract
Copyright © 2015, Mazandaran University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
Acknowledgements
Footnotes
References
  • 1. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008; 31: 247-69[PubMed]
  • 2. Masoud SA, Fakharian E. Assessment of serum magnesium, copper, and zinc levels in multiple sclerosis (MS) patients. IJPBS. 2007; 1(2): 38-42
  • 3. Keegan BM, Noseworthy JH. Multiple sclerosis. Annu Rev Med. 2002; 53: 285-302[DOI][PubMed]
  • 4. Shnek ZM, Foley FW, LaRocca NG, Gordon WA, DeLuca J, Schwartzman HG, et al. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Annals of Behavioral Medicine. 1997; 19(3): 287-94
  • 5. Skokou M, Soubasi E, Gourzis P. Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. Int Scholar Res Notice. 2012; 2012
  • 6. Hardmeier M, Schoonheim MM, Geurts JJ, Hillebrand A, Polman CH, Barkhof F, et al. Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography. PLoS One. 2012; 7(7)[DOI][PubMed]
  • 7. Sundgren M, Maurex L, Wahlin A, Piehl F, Brismar T. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis. Arch Clin Neuropsychol. 2013; 28(2): 144-55[DOI][PubMed]
  • 8. Burns MN, Nawacki E, Siddique J, Pelletier D, Mohr DC. Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis. Psychosom Med. 2013; 75(1): 76-82[DOI][PubMed]
  • 9. Sutherland G, Andersen MB, Morris T. Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training. J Behav Med. 2005; 28(3): 249-56[DOI][PubMed]
  • 10. McCabe MP, McKern S. Quality of life and multiple sclerosis: Comparison between people with multiple sclerosis and people from the general population. J Clin Psychol Med Set. 2002; 9(4): 287-95
  • 11. White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sport Med. 2004; 34(15): 1077-100
  • 12. Kneebone ,I, Dunmore E. Attributional style and symptoms of depression in persons with multiple sclerosis. Int J Behav Med. 2004; 11(2): 110-5[PubMed]
  • 13. Chen K, Fan Y, Hu R, Yang T, Li K. Impact of depression, fatigue and disability on quality of life in Chinese patients with multiple sclerosis. Stress Health. 2013; 29(2): 108-12[DOI][PubMed]
  • 14. Moran PJ, Mohr DC. The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med. 2005; 28(1): 35-41[PubMed]
  • 15. Alschuler KN, Ehde DM, Jensen MP. The co-occurrence of pain and depression in adults with multiple sclerosis. Rehabil Psychol. 2013; 58(2): 217-21[DOI][PubMed]
  • 16. Schumann R, Adamaszek M, Sommer N, Kirkby KC. Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis. Curr Pharm Des. 2012; 18(36): 5837-45[PubMed]
  • 17. Tullman MJ. A review of current and emerging therapeutic strategies in multiple sclerosis. Am J Manag Care. 2013; 19(2 Suppl)-7[PubMed]
  • 18. Crayton HJ, Rossman HS. Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther. 2006; 28(4): 445-60[DOI][PubMed]
  • 19. Ghafari S, Ahmadi F, Nabavi M, Anoshirvan K, Memarian R, Rafatbakhsh M. Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis. J Clin Nurs. 2009; 18(15): 2171-9[PubMed]
  • 20. Chang BH, Dusek JA, Benson H. Psychobiological changes from relaxation response elicitation: long-term practitioners vs. novices. Psychosomatics. 2011; 52(6): 550-9[DOI][PubMed]
  • 21. Jorm AF, Morgan AJ, Hetrick SE. Relaxation for depression. J Cochrane Database Syst Rev. 2008; 8(4)
  • 22. Bernstein D, Borkovec T, Carlson K. Progressive relaxation training: a manual for the helping profession. 1992;
  • 23. McCallie MS, Blum CM, Hood CJ. Progressive muscle relaxation. J Human Behav Social Environ. 2006; 13(3): 51-66
  • 24. Firth N. Effectiveness of psychologically focused group interventions for multiple sclerosis: A review of the experimental literature. J Health Psychol. 2013; 19(6): 789-801[DOI][PubMed]
  • 25. Stepleman LM, Decker M, Rollock M, Casillas R, Brands T. Depression screening in Black Americans with multiple sclerosis. Psychol Health Med. 2014; 19(1): 33-9[DOI][PubMed]
  • 26. Kisic Tepavcevic D, Pekmezovic T, Stojsavljevic N, Kostic J, Dujmovic Basuroski I, Mesaros S, et al. Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study. Acta Neurol Belg. 2013; 113(4): 403-9[DOI][PubMed]
  • 27. Nielsen-Prohl J, Saliger J, Guldenberg V, Breier G, Karbe H. Stress-stimulated volitional coping competencies and depression in multiple sclerosis. J Psychosom Res. 2013; 74(3): 221-6[DOI][PubMed]
  • 28. O Donnchadha S, Burke T, Bramham J, O'Brien MC, Whelan R, Reilly R, et al. Symptom overlap in anxiety and multiple sclerosis. Mult Scler. 2013; 19(10): 1349-54[DOI][PubMed]
  • 29. Schroder A, Heider J, Zaby A, Gollner R. Cognitive behavioral therapy versus progressive muscle relaxation training for multiple somatoform symptoms: Results of a randomized controlled trial. Cog Thera Res. 2013; 37(2): 296-306
  • 30. Sarisoy G, Terzi M, Gumus K, Pazvantoglu O. Psychiatric symptoms in patients with multiple sclerosis. Gen Hosp Psychiatry. 2013; 35(2): 134-40[PubMed]
  • 31. Wood B, van der Mei IA, Ponsonby AL, Pittas F, Quinn S, Dwyer T, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler. 2013; 19(2): 217-24[DOI][PubMed]
  • 32. Jones KH, Ford DV, Jones PA, John A, Middleton RM, Lockhart-Jones H, et al. A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register. PLoS One. 2012; 7(7)[DOI][PubMed]
  • 33. Ghajarzadeh M, Sahraian MA, Fateh R, Daneshmand A. Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran. 2012; 50(4): 244-9[PubMed]
  • 34. Sjonnesen K, Berzins S, Fiest KM, M. Bulloch AG , Metz LM, Thombs BD, et al. Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. Postgrad Med. 2012; 124(5): 69-77[DOI][PubMed]
  • 35. Pozzilli C, Schweikert B, Ecari U, Oentrich W, Bugge JP. Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study. J Neurol. 2012; 259(11): 2319-28[DOI][PubMed]
  • 36. Dubayova T, Krokavcova M, Nagyova I, Rosenberger J, Gdovinova Z, Middel B, et al. Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis. Qual Life Res. 2013; 22(6): 1353-60[DOI][PubMed]
  • 37. Fiest KM, Patten SB. The multiple sclerosis depression rating scale. Expert Rev Neurother. 2012; 12(9): 1053-5[DOI][PubMed]
  • 38. Labuz-Roszak B, Kubicka-Baczyk K, Pierzchala K, Machowska-Majchrzak A, Skrzypek M. Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis. Neurol Neurochir Pol. 2012; 46(4): 309-17[PubMed]
  • 39. Moore P, Hirst C, Harding KE, Clarkson H, Pickersgill TP, Robertson NP. Multiple sclerosis relapses and depression. J Psychosom Res. 2012; 73(4): 272-6[DOI][PubMed]
  • 40. Brown RF, Valpiani EM, Tennant CC, Dunn SM, Sharrock M, Hodgkinson S, et al. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother. 2009; 82: 41-56[DOI][PubMed]
  • 41. Kehler MD, Hadjistavropoulos HD. Is health anxiety a significant problem for individuals with multiple sclerosis? J Behav Med. 2009; 32(2): 150-61[DOI][PubMed]
  • 42. Skerrett TN, Moss-Morris R. Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms. J Psychosom Res. 2006; 61(5): 587-93[DOI][PubMed]
  • 43. Isa MR, Moy FM, Abdul Razack AH, Zainuddin ZM, Zainal NZ. Impact of applied progressive deep muscle relaxation training on the level of depression, anxiety and stress among prostate cancer patients: a quasi-experimental study. Asian Pac J Cancer Prev. 2013; 14(4): 2237-42[PubMed]
  • 44. Cafarella PA, Effing TW, Usmani ZA, Frith PA. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology. 2012; 17(4): 627-38[PubMed]
  • 45. Vazquez FL, Torres A, Blanco V, Diaz O, Otero P, Hermida E. Comparison of relaxation training with a cognitive-behavioural intervention for indicated prevention of depression in university students: a randomized controlled trial. J Psychiatr Res. 2012; 46(11): 1456-63[DOI][PubMed]
  • 46. Hashim HA, Hanafi Ahmad Yusof H. The effects of progressive muscle relaxation and autogenic relaxation on young soccer players' mood states. Asian J Sports Med. 2011; 2(2): 99-105[PubMed]
  • 47. Chang BH, Casey A, Dusek JA, Benson H. Relaxation response and spirituality: Pathways to improve psychological outcomes in cardiac rehabilitation. J Psychosom Res. 2010; 69(2): 93-100[DOI][PubMed]
  • 48. Lolak S, Connors GL, Sheridan MJ, Wise TN. Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom. 2008; 77(2): 119-25[DOI][PubMed]
  • 49. Persson AL, Veenhuizen H, Zachrison L, Gard G. Relaxation as treatment for chronic musculoskeletal pain–a systematic review of randomised controlled studies. Phys Ther Rev. 2008; 13(5): 355-65
  • 50. Pawlow LA, O'Neil PM, Malcolm RJ. Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003; 27(8): 970-8[DOI][PubMed]
  • 51. McGrady AV, Kern-Buell C, Bush E, Devonshire R, Claggett AL, Grubb BP. Biofeedback-assisted relaxation therapy in neurocardiogenic syncope: a pilot study. Appl Psychophysiol Biofeedback. 2003; 28(3): 183-92[PubMed]
  • 52. Sloman R. Relaxation and imagery for anxiety and depression control in community patients with advanced cancer. Cancer Nurs. 2002; 25(6): 432-5[PubMed]
  • 53. Weber C, Arck P, Mazurek B, Klapp BF. Impact of a relaxation training on psychometric and immunologic parameters in tinnitus sufferers. J Psychosom Res. 2002; 52(1): 29-33[PubMed]
  • 54. Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology. 2001; 10(6): 490-502[PubMed]
  • 55. Artemiadis AK, Vervainioti AA, Alexopoulos EC, Rombos A, Anagnostouli MC, Darviri C. Stress management and multiple sclerosis: a randomized controlled trial. Arch Clin Neuropsychol. 2012; 27(4): 406-16[DOI][PubMed]
  • 56. Molina-Rueda F, Perez de la C. Multiple sclerosis and relaxation techniques. J Revista Iberoamericana Kinesiology and Physiotherapy. 2009; 12(1): 28-34
  • 57. Ghafari S, Ahmadi F, Nabavi M, Memarian R. Effects of applying progressive muscle relaxation technique on depression, anxiety and stress of multiple sclerosis patients in Iran National MS Society. Pejouhesh. 2008; 32(1): 45-53
  • 58. Dabson KE, Mohamadkhani P. Psychometric characteristics of BDI-II in patients of MDD. J Rehab. 2007; 8(29): 104-11
  • 59. Wang YP, Gorenstein C. Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clinics (Sao Paulo). 2013; 68(9): 1274-87[PubMed]
  • 60. Wilson P. Immediate Relief. 2000;
  • 61. Sadok VA, Kaplan H. Kaplan and Sadock' synopsis of psychiatry: behavioral sciences - clinical psychiatry. 2003;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments